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Effects of Various Hormones on
Human Carcinoma Cell Proliferation
Y.L GAO\ B.S. LEUNG .. , A.H. POTTER.. . , W.C.Y. Yu"***
Abstract - Cell proliferation of a mammary adenocarcln.oma cell line, CAMA-1. is affected
by a number of steroid hormones and orolactin in lono-term cultures. Estrogenic compounds stimulate cell growth while antiestrogenic compounds inhibit it. Prolactrn can
synergise the estrogenic effect. Progesterone, glucocorticoid or androgen reduce cell
p~oliferation. Dihydrotestosterone is a very potent inhibitor,- effective at as low as 10 pM,
and its effect is independent of estrogen action. Cortisol is a less effective inhibitor at
concentrations below 10 nM; at these,levels,cortisol exhibits a slight inhibition which appears to be unrelated to estrogenic action. However, at higher concentrations, cortisol
marKedly reduces ceil division and drastically diminishes the stimulatory effect of
estrogen on cell growth. The precise mechanisms of hormone actions on cell proliferation
remain to be explored.
Breast c;;incers of both humans anti animals are affected by
many hormones (Leung, 197S, 1981). Since the studies by
Huggins and his co-workers (1962) both additive and ablative
hormonal therapies have been extensively used for the treatmenr
of disseminated breast cardnoma. A number of carcinogen-induced mammary tumor modds have been developc.>d in animals
for the srudy of single and combined hormone effe,.__-t:s on tumor
growth and cellular events (Leung 1978, Leung, 1982). Despite
the obvious merits and information generated from these
smdies, the exact prlmar.Y or secondary effect of a patricular
hormone cannot be differentiated because of the comple.x hor~
rnonal environment in the intact animal. It is known that
regularory control mech,misms exist to govern the secretion of
gonadal and pituitary hormones. These feed-back mechanisms
are invariably perturbed by the alteration of scrum hunnone
1evcls via exogenous administration of either gonadal or pituitary
ho rmones or by the deletion of any one of them through endocrine glaf1d ablation. For this reason, the removal of estrogen
by ovariectotnY plus adrenalectomy provides essenrially the same
rialliative benefits for mammary carcinoma patients as those sub-jeered to hypophYsectomY. Similar 6bservations were reported
in animal models. Furthermore, it has become evident that
several hormo nes interact to achieve a particular effect. Some of
these hormones, such as prolaain. insulin or thyroid hormon.es1
are permissive in their action; that is, only suboptimal levels
need to be present to pennit the full expression of another hormone, e.g. estrogen. Therefore, unequivoc,il demonstration of
the discrete role of a particular hormone or the combined effects
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of several hormo nes is difficult ro achieve, ln recenr years, a
number of laboratories were successful in obtaining hormoneresponsive cell lines for investigating the effects of different hormones in vitro. Although cell culture experiments have manv
limirations, the advantages are also obvious: cells can be cultured
in chemically defined media so char uncertainties due to hor~
mane foed-back c011dirlons in viw can be prevented.
Estrogen, progesterone and prolaccin are three major hormones that affea: the growth of mammary tumors induced in
rodents by· the administration of carcinogen (Huggins et al.,
1962, Leung, 1978, and Leung, 1982). Similarly, exacerbation of
mammary rumor growth in patients by low level,, ofestrogen has
been documented. Pharmacological levels of progesterone,
glucocorticoid, androgen or estrogen inhibit experimental rumor
growth and are often used for hormonal rherapy in disseminated
breast cancer (McGuire et al., 1975). There is very liccle information' in the literature indicating prolactin involvement in
liuman breast cancer. For the past several years, investigations
on the role ofan individual hormone, and the interactions of differe(lt honm:mes, were cond1,1cted in this laboratory by the use of
a human adenacarcinoma cell line, CAMA-1, growing in long
term culture (Leung, 1978, Leung et al., 1981, 1982 and Yu et al.,
1981). This communication addresses the synergistic or antagonisdc effects of prolactin, progesterone, androgen and
g)ucorcorticoid with estrogen on cell growth.

Description of the cell culture

CA!v1A-1 originate-cl from the malignanr pleural effusion of a
J:X)5t·mt::nupausa1 woman with adenocarcinoma of the breast
(Leung er al., 198!). These cells have been maintained and
culrivat~d as monolayers in minimum essential medium (MEM)
with E,irle's salts and supplemented with 2mM L-glutamine,
penicillin (!00 unics/ ml}, streptomycin (100 micrograms/ ml),
nnd 25 percent FBS. Cells were plated routinely in MEM at a
density of 106 cells in a T-75 flask, or 5 x 105 cells in T-25 flask,
without further change of medium for 7 days, and were incubated in humidified atmosphere of 95 percent air -5 percent
CO2 at 37 degrees. At the end of 7 days, cells were lifted from
the surface of the flask by rrysin-EDT A (0.025 percent) in
Hank's balanced salt solution with calcium and magnesium. A11
3

cultures were supplemented with 1 nM estradioJ. For experimenral media endogenous hormones were removed from serum
using dexrran-coated charcoal (DC) to absorb ~teroid · and other
components from FBS (Leung, et al., 1981), This serum (DG
FBS) was used for the determination f hormonal effects on cell
proliferation during culture. Hormones were added during
plating as indicated in each experimental flasks were plated with
5 x I04 cells.
Due to a significant level of peptide hormones present in
serum, a serum substitute composed of vitamins, pho pholipid
and various defined nutrients (Leung, et al., 1981) was prepared
tO srudy the effects of prolactin and other peptide harm nes on
ell proliferation. Upra_ke of thYmidine by 2-hr pulse labeling has
been detailed in a previous publication (Yu et al., 198 1),
Effect of estrogen on cell proliferation

The effects of estrogen in stimulating cell proliferarion in DCFBS have been sn,idied extensively in this laboratory (Leung, et
al., 1981, 1982; Yu et al., 1981). The addition of estradio\ to
culture medium accelerated cell growth as compared with controls (no estradiol). A subline of CAMA-1 which was continuously passaged in FBS in the absence of added esrradiol
exhibited an apparent partial loss ofresponse to estradiol-induced
tlwmidine (TOR) uptake. Thus, the CAMA-IR ublinc which
was supplemented with lnM e tradio! retained a mean of an approximately rwo-fo]d increase in IDR uptake in response to
estradfol stimulation while the IN subline, with6ut addeg·
estracliol fn culture, was refracrm:y. These two sub lines exhibit
different growth rates and levels of steriod receptors, severa l
researchers have indicated. However, borh sublines retained
their ability to respond to estradiol in the induction of
progesterone receptor. These effects of esrradiol on cell
prollferation and cellular events are dose-dependent and are
reproducible.
The effects of other estrogens and antagonists on cell
proliferation were investigated. As shown in Fig. 1, the classical
estrogens, such as estriol, estrone, 17-beta estradiol and synthetic
esrrogen-like compounds such as dierhylstilbestrol were all effective in stimulating cell growth. Nevertheless, 17-alpha estradiol,
which is known to be antagonistic tO manY estrogen-iniciaccd
cellular events, markedly inhibited cell growth.
Effect of other steroids noted

Both progesterone and d!hydrotestosterone (DH1) were very
effective in inhibiting cell proliferation (Fig. 1). These results are
consistent with clinical observations where patients with hormone responsive mammary tumors respond objectively to additive therapy with progescin or androgenic drugs. At dosages as
low as lOpM, DHT can exert a marked inhibition of cell growth
in comparison with controls (Fig. 2). In the presence of estradiol,
cell numbers during harvest were consistently higher than cell
plated in its absence. The degree of inhibition by DHT in
esq::adiol-treated cultures is not different from that in estradioI-1
free controls. These data suggest that DHT may be acting
through a mechanism different from that of estradiol, which accelerat · cell proliferation. DHT .levels higher th an IO pM did
n0t c(luse greater inhibi!ion, regard!es of whether estradiol was
added to the culture medium.
Producing responses similar to the clinical effects of
progesterone and DHT, glucocorticoids are effective drugs for
palliating hormone-sensitive mammary tumors. Cortisol showed
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Figure 1. - Effects of different steroid hormones on the
percentage of cell yield. Cells were plated in medium containing 10 percent DCFBS and were harvested 7 days later.
Ez, estradlol: E1, estrone; E3, es!riol; DES, diethylstilbestrol;
Pg, progesterone; DHT, dihydrotestosterone; bars, S.D.

little inh ibition at low levels (10 pM to. l nM) but wa very effective in reducing cell growth :cJt levels higher than 10 nM (Fig. 3),
Cell proliferation wa. accelerated when both c:,uadiol and ortisol were added to rhe cultures, High levels of cortisol indL1 cd
m re pr nounccd inhibitory effect on estradiol-rreated cells. It
therefore appears that the slight inhibition Induced by cortisol is
not c::;tn)cliol mediated. I-I wever, at higher levels, corti. ol rnoy
also turn off t he cscradiol srimularory mechanism.
Effects of prolactin
When cultured in the absence of serum, CAMA-1 cells do not
prollfenitc and cellular uptake of lDR is very low, pre umably
due to the lack of adequate nutrientS and growth-promoting factors. The effect of estradiol on lDR uptake is dependent on the
proportion of serum added to the medium; in IO percent DCFBS, estradiol stimulates a two-(old or more TOR uptake above
the level of controls without esti·adiol. This stimu lation i not
observed in a IO percenc scrum substitute (SS), or .it best, is
minimally observed with to percent SS plus I percent DCFBS
(Leung, et al., 1981). The addition of prolactin to emadioltTt:ated cultures in the to percent SS alone or 10 percent SS plus
1 percent DCFBS markedly increa es TOR uptake over controls
(without hormone) or with either estradiol or prolactln alone.
However, in 10 percent DCFBS, prolactin suppresses estradiol
stimulation.
The effect of prolactin and estradiol on cell proliferation was
studied in IO percent OCFBS and in 10 percent SS plw; 1 percent DCFBS (Leung, et al., 1981). Without exogenou hormom~s, CAMA-1 cells .proliferate bener in 10 percent SS plus I
.percent OCFBS than in 10 percent DCFBS. While estradiol
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Figure 2, - Effect of dihydrotestosterone (DHn concentration on cell yield. Cells were plated in medium contain ing
10 percent DCFBS and the indicating DHT concentrations
were harvested 7 days tater. Opeh circles, no E2; closed cir·
cles, 1 nM E2; C, no DHT; bars, S.D.
alone stimulates proliferation in either mediumi ic i much more
effective in IO percenl OCF8$. This result ·hows that crtain
growth factors are presenc in the ~rum, and esrrogenic effect
mi_ght be rncuiated via these facmrs. ln contrnst to TOR uptake
described above, prolactin 11 rm,-11ly ha n ·ynergiscic effect on
esrradiol-induced proliferati n. However, "aged" pr lactin
(refrigerated for one. day or fr(.}'Z.cn at -70°C for several days) Wa5
shown to enhimce the effect of estradiol in cell growrh (Fig. 4).

information, for predicting the objective.response of a pat!ent to
hormone therapy. Funherrnore, a significantly h(gher survival
rate of breast cancer patients with receptor-positive rumors than
receptor-negative tumors was noted. CAMA-1 cells contain
estrogen receptors {Leung, 1978, Leung et al., 1982), progesterone receptors (Yu er al., 1981), also glucocorticoid and
a ndrogen re<.eptors. These cesults are in a'greemem with
findings of other investigators who observed these four classical
steroid receptors in mammary rumor ~pecimens and other
mammary carcinoma cell lines in long-tenn culture. The
clinical importance of androgen and g)ucocorticoid receptors in
mammary carcinoma is uncertain.
Although it is well documented that some steroid-induce~
cellular events are mediated by these receptor molecules, there is
no direct evidence indicating chat cell proliferation is receptorrnediated. Therefore, whether rhe presence of these fout classes
of teroid receptor protein in CAMA-l cells is ~sociated with
the observed sdmulatory or inhibitory action of these steroid
hormones roust await futher experimemacion. There is evidence
demonstrating that in the absence of receptor proteiru; in cells,
che probabilitY of the tissue responding to hormonal
manipulation is poor (McGu1re er al., 1975; Cancer Supplement
1g80, Leung, l97 ). Nevercheless, the mere presence of its recepror i not the sole fa tor for responsiveness of the tissue co a particular hormone. The cellular mechanism of action for the p~r
ticular hormone rnuSt be operational without any defect or trr
pairment . That is, rhe reroid-rece.pror comple.'< must be able ro
be activated, to translocate to the nuclei, and m interact with
the acceptor protein located in the chromatin.
Interestingly, androgen is markedly inhibit ry ro CAMA-1
cells as it is for many clinical marnmary carcinomas but i
stimulatory ro
:mc.lrogen-sen iti c mouse mammory cell line,
S1 l (King et a L, 1976) which al ·o contains .indrogen recepto rs .
If proliferation is mediated by andr gen rccepmr~, these
diametrically o pposite results of the two cell lines inJirnte 1hM
mher facmr( ) must also be present ro determine the stimulatory

,m

Presently, there is no adequate eXplanation for che diversity of
the observed prolactin effects on IDR uptake and cellular
proliferation. Additional work is also needed to elucidare rhe e feet of pr lactin , particulnrly with respect t0 ics role in cell cy le
kinecics i.n rhe presence or absence of esrradiol.

Mechanism of steroid hormone action
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sen~itiv . Although exrcn ive srudie have been undertaken -in
the past three decades regnrding the roles of steroid hormones in
proliferation, l.irtle is kn wn concerning the mechanism of action of an individual hormone, let alone the mechanism of their
interactions. Recemly, abundam evidence (Clark and Peck,
1979) has accumulated to how that the initial action of a steroid
hormone in itS target tissues is to bind to a specific protein
molecule, termed a receptor. The steroid-receptor complc.x in
the ytoplasm undergoes transformation or activation immediately following interaction with the specific steroid ligand.
This complex then moves into the nudeus and interacts with
chromarin material resulting in the initiation of gene rranscriprion, and ulcimarely 1 pr rein synthesis, cellular function
and differentiation of the tissue. Receptors for estrogen , progesrcrone, androgen and glucorcorticoid · are present in some
m:1mmary cells. Recently, it has ~ n documented (McGuire et
al., 197 c nd Cancer Supplement, 1980) that the presence of
estrogen recei ror and prog rerone receptors in mammary carcinoma i the best ingle index, independent of any clinical
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Figure 3. - Effect of cortisol concentration on cell yield.
Cells were plated in the medium containing 10 percent DCFBS and the indicated cortisol eoncentration, and were harvested 7 days later. Open circles, no E,; closed circles, 1 nM
EDC, no cortisol; bars, S.D.

REFERENCES

CANCER SUPPLEMENT 1980. Steroid Receptors in Breast
Cancer. An NIH Consensus Devdppment Confere~ce,
Bethesda, Maryland,June 27-29, 1979.

.
,_

1.8

-

-

CLARK, J.H. and PECK, E.J. , ]R. 1979. Female Sex Steroids
Receptors and Function. Springer-Verlat Berlin, Heidelberg,
New York.

10

...

10

1.6

+

-

.

)(

CD

.c

E

:,

1.4

-

rl-

KING, R.J.B., CAMBRAY, G.]. and ROBINSON, J.H. 1976.
The role of receptors in the steroidal regulation of rumor cell
proliferation. J. Steroid Biochem. 7.

--

C

-

GI

0

HUGGINS, C., MOON, R.C. and MORI!, S. 1962. Extinction
of experim ental mammary cancer, l. Estradiol-17 beta and
progesteron e. Proc. Natl. Acad. Sci. U.S.A. 48 .

1.2

-

LEUNG, B.S. 1978. Hormonal dcpendern.-:y of experiment:11
breast can er. In: W.L. McGuire, (ed.). Hormones, Receptors
and Breast Cancer. Raven Press, New York.

~

0

C

E

Prl

Prl+E

Figure 4. - Effect of prolactin (Prl) on cell yield. Cells were
plated in MEM supplenlented with 10 percent seru m substitute and 1 percent DCFBS (Leung et al , 1981) and were
harvested 7 days later. C, control · E, estradiol (1 nM); Prl, 1
microgram/m l. Hormones were added to the med ium during
plating; bars, S.D.

or inh ibiwry r ponse the ccil. 1t i possible chat the androgen
receptors in C AMA-l cells arc- q uite diffe rent fro m those f the
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rrue fr'll· the effecr of glu, corcicoid in C AMA-1 cells and ocht>r
glucocortkoid-re ponslve tumors.
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upon 1m1mmnry ·nrdnornt1 cell proltfer.ation in vitro. Pralacrin
appea r~ to serve ns ;:1 growrh focmr in rhe presence of estrogen.
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